‘A Comparative Study To Assess The Effectiveness Of Covaxin And Covishield To Control Covid 19 Among The Adults Residing In Selected Urban Area’.

Abstract

This study compares the effectiveness of Covaxin and Covishield vaccines in preventing COVID-19 among adults in a specific urban area. It assesses how each vaccine controls infections and their side effects, while also exploring the relationship between vaccine complications and demographic factors. Objectives include evaluating the vaccines' effectiveness and testing hypotheses on significant differences between them and their demographic associations. A non-experimental survey design involving 200 adults was used, with data collected and analyzed statistically. Results showed Covaxin's effectiveness at 0.98 and Covishield's at 0.99, with a Z-test showing no significant difference in RT-PCR negative cases (p = 0.56). Covaxin had an average side effect score of 16.44, while Covishield had 13.07. Significant associations were found between vaccine-related complications and age, family type, and marital status, but not with sex, religion, or education.